SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PTC Therapeutics 12-Month Price Target Raised to $98.31

The 12-month price target for PTC Therapeutics was raised to $98.31, implying 53% upside.

PTCT

Related stories